Evidence map›Paper›PMID 26907467›Full record

ArticleScientific reports2016

Novel Y-chromosomal microdeletions associated with non-obstructive azoospermia uncovered by high throughput sequencing of sequence-tagged sites (STSs).

Xiao Liu, Zesong Li, Zheng Su, Junjie Zhang, Honggang Li, Jun Xie, Hanshi Xu, Tao Jiang, Liya Luo, Ruifang Zhang and 14 more

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Copy Number Variations in Female Infertility in China.Balkan journal of medical genetics : BJMG · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Xiao LiuBGI-Shenzhen, Shenzhen 518083, China.
Zesong LiShenzhen Key Laboratory of Genitourinary Tumor, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen 518035, China.
Zheng SuBGI-Shenzhen, Shenzhen 518083, China.
Junjie ZhangShool of bioscience &bioengineering, South China University of Technology, Guangzhou, China.
Honggang LiFamily Planning Research Institute/The Center of Reproductive Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Jun XieGuangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center, Shenzhen 518036, China.
Hanshi XuBGI-Shenzhen, Shenzhen 518083, China.
Tao JiangBGI-Shenzhen, Shenzhen 518083, China.
Liya LuoShenzhen Key Laboratory of Genitourinary Tumor, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen 518035, China.
Ruifang ZhangBGI-Shenzhen, Shenzhen 518083, China.
Xiaojing ZengBGI-Shenzhen, Shenzhen 518083, China.
Huaiqian XuBGI-Wuhan, Wuhan, China.
Yi HuangShenzhen Key Laboratory of Genitourinary Tumor, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen 518035, China.
Lisha MouShenzhen Key Laboratory of Genitourinary Tumor, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen 518035, China.
Jingchu HuBGI-Shenzhen, Shenzhen 518083, China.
Weiping QianGuangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center, Shenzhen 518036, China.
Yong ZengThe Center of Reproductive Medicine, Shenzhen Zhongshan Urological Hospital, Shenzhen 518045, China.
Xiuqing ZhangBGI-Shenzhen, Shenzhen 518083, China.
Chengliang XiongFamily Planning Research Institute/The Center of Reproductive Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Huanming YangBGI-Shenzhen, Shenzhen 518083, China.
Karsten KristiansenDepartment of Biology, University of Copenhagen, Copenhagen 2200, Denmark.
Zhiming CaiShenzhen Key Laboratory of Genitourinary Tumor, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen 518035, China.
Jun WangBGI-Shenzhen, Shenzhen 518083, China.
Yaoting GuiGuangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center, Shenzhen 518036, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Y-chromosomal microdeletion (YCM) serves as an important genetic factor in non-obstructive azoospermia (NOA). Multiplex polymerase chain reaction (PCR) is routinely used to detect YCMs by tracing sequence-tagged sites (STSs) in the Y chromosome. Here we introduce a novel methodology in which we sequence 1,787 (post-filtering) STSs distributed across the entire male-specific Y chromosome (MSY) in parallel to uncover known and novel YCMs. We validated this approach with 766 Chinese men with NOA and 683 ethnically matched healthy individuals and detected 481 and 98 STSs that were deleted in the NOA and control group, representing a substantial portion of novel YCMs which significantly influenced the functions of spermatogenic genes. The NOA patients tended to carry more and rarer deletions that were enriched in nearby intragenic regions. Haplogroup O2* was revealed to be a protective lineage for NOA, in which the enrichment of b1/b3 deletion in haplogroup C was also observed. In summary, our work provides a new high-resolution portrait of deletions in the Y chromosome.

Indexed as

AlgorithmsAzoospermiaCase-Control StudiesChromosomes, Human, YDNA Mutational AnalysisGenetic Association StudiesHigh-Throughput Nucleotide SequencingHumansMaleSequence DeletionSequence Tagged Sites

Identifiers

PMID26907467
PMCPMC4764820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.